BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12587850)

  • 1. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
    Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
    Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive functioning in first-episode schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 2002 May; 27(3):188-92. PubMed ID: 12066448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Do alcohol or drug abuse induce schizophrenia?].
    Hambrecht M; Häfner H
    Nervenarzt; 1996 Jan; 67(1):36-45. PubMed ID: 8676987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.
    Rund BR; Melle I; Friis S; Larsen TK; Midbøe LJ; Opjordsmoen S; Simonsen E; Vaglum P; McGlashan T
    Am J Psychiatry; 2004 Mar; 161(3):466-72. PubMed ID: 14992972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis.
    Potvin S; Joyal CC; Pelletier J; Stip E
    Schizophr Res; 2008 Mar; 100(1-3):242-51. PubMed ID: 17614260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is there a temporal correlation between substance abuse and psychosis in adolescents?].
    Holtmann M; Becker K; Hartmann M; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):97-103. PubMed ID: 12053879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychotic disorders and drug abuse in adolescents].
    Fleischhaker C; Priemer K; Schulz E; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):87-95. PubMed ID: 12053878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarifying the diversity of first-episode psychosis: Neuropsychological correlates of clinical symptoms.
    Lindsberg J; Poutiainen E; Kalska H
    Nord J Psychiatry; 2009 Nov; 63(6):493-500. PubMed ID: 19685368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
    Jockers-Scherübl MC
    Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome.
    Addington J; Saeedi H; Addington D
    Schizophr Res; 2005 Oct; 78(1):35-43. PubMed ID: 15978781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.